speb/financial-data huggingface dataset:
AGNCN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 1634000000.00
AGNCN income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 35000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 1634000000.00
AGNCN income_statement (quarterly, 2025-03-31) — Pretax Income: 50000000.00
AGNCN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -17079000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Receivables: 1000000.00
AGNCN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -8872000000.00
AGNCN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 19000000.00
AGNCN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 11613000000.00
AGNCN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 19000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Share Issued: 949000000.00
AGNCN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -4000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10042000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7882000000.00
AGNCN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
AGNCN balance_sheet (quarterly, 2025-03-31) — Total Assets: 95889000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10104000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Total Debt: 62000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10042000000.00
AGNCN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 85847000000.00
AGNCN cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -1183000000.00
AGNCN income_statement (quarterly, 2025-06-30) — +Total Revenue: -112000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 18575000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 6002000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1718000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1644000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 656000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 23234000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -394000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3418000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3444000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 180000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -17000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 25000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 8000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 154000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Common Stock: 10000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8713000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 799000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 106000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -178000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 164000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — End Cash Position: 1872000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 3418000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 180000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 177000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -274000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -450000000.00
AGNCN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Goodwill: 526000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 526000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Interest Expense: 668000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Interest Income: 830000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8773000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3444000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 6002000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 799000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 60000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 60000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 799000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income: -140000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -178000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -140000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -140000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -140000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -140000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -140000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Net Interest Income: 162000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 87000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 9821000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Normalized Income: -140000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 180000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 544000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Operating Revenue: -112000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1041700000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -450000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 10000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Other Payable: 392000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Payables: 556000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 556000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 67500000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 1634000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 38000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 1634000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Pretax Income: -140000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -23609000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Receivables: 0.00
AGNCN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -9422000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 18000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 23696000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 18000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Share Issued: 1041700000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 8000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 10347000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8187000000.00
AGNCN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Total Assets: 102021000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 10407000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Total Debt: 60000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 10347000000.00
AGNCN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 91674000000.00
AGNCN cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -270000000.00
AGNCN income_statement (quarterly, 2025-09-30) — +Total Revenue: 836000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 18892000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 8010000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1872000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1979000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 450000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 23310000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -416000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 5223000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5337000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 153000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -48000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 17000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -31000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 39000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Common Stock: 11000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9476000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 309000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 87000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 764000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 170000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — End Cash Position: 1911000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 5223000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 153000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 81000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 688000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -389000000.00
AGNCN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 20000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Goodwill: 526000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 526000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Interest Expense: 755000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Interest Income: 903000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9534000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5337000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 8010000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 643000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 58000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 58000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 309000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income: 806000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 764000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 806000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 806000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 806000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 806000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 806000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Net Interest Income: 148000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5551000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -3000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10918000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Normalized Income: 806000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 153000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 117000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Operating Revenue: 836000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1072700000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -389000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 10000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Other Payable: 1225000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1502000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Payables: 1395000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1395000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 81300000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 1968000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 42000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 1968000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Pretax Income: 806000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -22008000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Receivables: 1502000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -9038000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 20000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 16457000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 20000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Share Issued: 1072700000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 9000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11444000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8950000000.00
AGNCN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
AGNCN balance_sheet (quarterly, 2025-09-30) — Total Assets: 108969000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11502000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Total Debt: 58000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11444000000.00
AGNCN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 97525000000.00
AGNCN cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -805000000.00
AGNCN income_statement (annual, 2025-12-31) — +Total Revenue: 1797000000.00
AGNCN income_statement (quarterly, 2025-12-31) — +Total Revenue: 995000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 19261000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 19261000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 7405000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 7405000000.00
AGNCN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1771000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1911000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Capital Stock: 1979000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1979000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 450000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 450000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18357000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18357000000.00
AGNCN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1601000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -428000000.00
AGNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 25182000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11059000000.00
AGNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -25864000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11356000000.00
AGNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 653000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 128000000.00
AGNCN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -151000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -69000000.00
AGNCN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 53000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -32000000.00
AGNCN cash_flow (annual, 2025-12-31) — Change In Working Capital: -98000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -101000000.00
AGNCN cash_flow (annual, 2025-12-31) — Changes In Cash: -29000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -169000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Common Stock: 11000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Common Stock: 11000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10425000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10425000000.00
AGNCN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1973000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 356000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 6000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 6000000.00
AGNCN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1509000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 908000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Dividends Payable: 182000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 182000000.00
AGNCN cash_flow (annual, 2025-12-31) — End Cash Position: 1742000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — End Cash Position: 1742000000.00
AGNCN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 25182000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 11059000000.00
AGNCN cash_flow (annual, 2025-12-31) — Free Cash Flow: 653000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 128000000.00
AGNCN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 529000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 26000000.00
AGNCN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1122000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 789000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -323000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -323000000.00
AGNCN income_statement (annual, 2025-12-31) — General And Administrative Expense: 87000000.00
AGNCN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 30000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Goodwill: 526000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Goodwill: 526000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCN income_statement (annual, 2025-12-31) — Interest Expense: 2848000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Interest Expense: 738000000.00
AGNCN income_statement (annual, 2025-12-31) — Interest Income: 3523000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Interest Income: 944000000.00
AGNCN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 2793000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Invested Capital: 10481000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10481000000.00
AGNCN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -25864000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11356000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Investments And Advances: 7405000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 7405000000.00
AGNCN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2307000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 356000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Long Term Debt: 56000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 56000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56000000.00
AGNCN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -12000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1973000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 356000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income: 954000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1509000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 908000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 954000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 954000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 954000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1670000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 954000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 954000000.00
AGNCN income_statement (annual, 2025-12-31) — Net Interest Income: 675000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Net Interest Income: 206000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -27271000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -16341000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -12000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -12000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3000000.00
AGNCN cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 334000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
AGNCN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 11867000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 11867000000.00
AGNCN income_statement (annual, 2025-12-31) — Normalized Income: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Normalized Income: 954000000.00
AGNCN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 653000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 128000000.00
AGNCN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1611000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -314000000.00
AGNCN income_statement (annual, 2025-12-31) — Operating Revenue: 1797000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Operating Revenue: 995000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1107600000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1107600000.00
AGNCN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -323000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -323000000.00
AGNCN income_statement (annual, 2025-12-31) — Other Non Interest Expense: 40000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 11000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Other Payable: 193000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Other Payable: 193000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Other Receivables: 152000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Other Receivables: 152000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Payables: 375000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Payables: 375000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 375000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 375000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 81300000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 81300000.00
AGNCN balance_sheet (annual, 2025-12-31) — Preferred Stock: 1968000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1968000000.00
AGNCN income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 161000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 46000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1968000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1968000000.00
AGNCN cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 334000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
AGNCN income_statement (annual, 2025-12-31) — Pretax Income: 1670000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Pretax Income: 954000000.00
AGNCN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -98496000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -35800000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Receivables: 152000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Receivables: 152000000.00
AGNCN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -12000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Retained Earnings: -8524000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -8524000000.00
AGNCN income_statement (annual, 2025-12-31) — Salaries And Wages: 87000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 30000000.00
AGNCN cash_flow (annual, 2025-12-31) — Sale Of Investment: 71225000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 19459000000.00
AGNCN income_statement (annual, 2025-12-31) — Selling General And Administration: 87000000.00
AGNCN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 30000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Share Issued: 1107600000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Share Issued: 1107600000.00
AGNCN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 13000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 12393000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 12393000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 9899000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 9899000000.00
AGNCN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
AGNCN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
AGNCN balance_sheet (annual, 2025-12-31) — Total Assets: 115077000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Total Assets: 115077000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Total Capitalization: 12449000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 12449000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Total Debt: 56000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Total Debt: 56000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 12393000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 12393000000.00
AGNCN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 102684000000.00
AGNCN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 102684000000.00
AGNCN cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -2733000000.00
AGNCN cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -475000000.00
AGNCN income_statement (quarterly, 2026-03-31) — +Total Revenue: -114000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 19656000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 7485000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1742000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1979000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 493000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 20001000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -451000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2223000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1995000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 387000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 23000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 33000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 56000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 615000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Common Stock: 11000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10213000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 401000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 440000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -192000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 182000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — End Cash Position: 2357000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2223000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 387000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -74000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -433000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -331000000.00
AGNCN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 23000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Goodwill: 526000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Interest Expense: 731000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Interest Income: 1050000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1995000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 7485000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 401000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -57000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 401000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income: -148000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -192000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -148000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -148000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -148000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -148000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -148000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Net Interest Income: 319000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1127000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -57000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -57000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 11655000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Normalized Income: -148000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 387000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -456000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Operating Revenue: -114000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1147800000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -331000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 11000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Other Payable: 933000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Payables: 1115000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1115000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 81300000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1968000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 44000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1968000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Pretax Income: -148000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -44707000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
AGNCN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -57000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -9123000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 23000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 43580000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 23000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Share Issued: 1147800000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: -6000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12181000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9687000000.00
AGNCN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AGNCN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Total Assets: 118897000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12181000000.00
AGNCN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 106716000000.00
AGNCN cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 889000000.00
AGNCO balance_sheet (annual, 2021-12-31) — Accounts Payable: 400000000.00
AGNCO cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -17000000.00
AGNCO cash_flow (annual, 2021-12-31) — Common Stock Payments: -281000000.00
AGNCO cash_flow (annual, 2021-12-31) — Preferred Stock Payments: 0.00
AGNCO cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -281000000.00
AGNCO income_statement (annual, 2022-12-31) — +Total Revenue: -1116000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14186000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 3677000000.00
AGNCO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1525000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Capital Stock: 1640000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1018000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 8956000000.00
AGNCO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -869000000.00
AGNCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -11392000000.00
AGNCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 11188000000.00
AGNCO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1013000000.00
AGNCO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 38000000.00
AGNCO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 69000000.00
AGNCO cash_flow (annual, 2022-12-31) — Change In Working Capital: 107000000.00
AGNCO cash_flow (annual, 2022-12-31) — Changes In Cash: 809000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Common Stock: 6000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6236000000.00
AGNCO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 526000000.00
AGNCO cash_flow (annual, 2022-12-31) — Common Stock Payments: -51000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 99000000.00
AGNCO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1295000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Dividends Payable: 100000000.00
AGNCO cash_flow (annual, 2022-12-31) — End Cash Position: 2334000000.00
AGNCO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -11392000000.00
AGNCO cash_flow (annual, 2022-12-31) — Free Cash Flow: 1013000000.00
AGNCO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 2916000000.00
AGNCO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2081000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -672000000.00
AGNCO income_statement (annual, 2022-12-31) — General And Administrative Expense: 41000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Goodwill: 526000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCO income_statement (annual, 2022-12-31) — Interest Expense: 625000000.00
AGNCO income_statement (annual, 2022-12-31) — Interest Income: 1590000000.00
AGNCO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 557000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Invested Capital: 6331000000.00
AGNCO cash_flow (annual, 2022-12-31) — Investing Cash Flow: 11188000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Investments And Advances: 3677000000.00
AGNCO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 671000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Long Term Debt: 95000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 95000000.00
AGNCO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -24000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 475000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income: -1190000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1295000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1190000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1190000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1190000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1190000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1190000000.00
AGNCO income_statement (annual, 2022-12-31) — Net Interest Income: 965000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 7187000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -24000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -24000000.00
AGNCO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 145000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7344000000.00
AGNCO income_statement (annual, 2022-12-31) — Normalized Income: -1190000000.00
AGNCO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1013000000.00
AGNCO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1714000000.00
AGNCO income_statement (annual, 2022-12-31) — Operating Revenue: -1116000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 574600000.00
AGNCO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -672000000.00
AGNCO income_statement (annual, 2022-12-31) — Other Non Interest Expense: 33000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Other Payable: 302000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Other Receivables: 120000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Payables: 402000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 402000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 67500000.00
AGNCO balance_sheet (annual, 2022-12-31) — Preferred Stock: 1634000000.00
AGNCO income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 105000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1634000000.00
AGNCO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 145000000.00
AGNCO income_statement (annual, 2022-12-31) — Pretax Income: -1190000000.00
AGNCO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -55509000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Receivables: 120000000.00
AGNCO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -24000000.00
AGNCO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -51000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Retained Earnings: -7284000000.00
AGNCO income_statement (annual, 2022-12-31) — Salaries And Wages: 41000000.00
AGNCO cash_flow (annual, 2022-12-31) — Sale Of Investment: 62696000000.00
AGNCO income_statement (annual, 2022-12-31) — Selling General And Administration: 41000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Share Issued: 574600000.00
AGNCO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7870000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5710000000.00
AGNCO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
AGNCO balance_sheet (annual, 2022-12-31) — Total Assets: 51748000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Total Capitalization: 7965000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Total Debt: 95000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7870000000.00
AGNCO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 43878000000.00
AGNCO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 3795000000.00
AGNCO income_statement (annual, 2023-12-31) — +Total Revenue: 251000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15281000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 4242000000.00
AGNCO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 2334000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Capital Stock: 1641000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 518000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13389000000.00
AGNCO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1005000000.00
AGNCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 14227000000.00
AGNCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -14672000000.00
AGNCO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -118000000.00
AGNCO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -892000000.00
AGNCO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 904000000.00
AGNCO cash_flow (annual, 2023-12-31) — Change In Working Capital: 12000000.00
AGNCO cash_flow (annual, 2023-12-31) — Changes In Cash: -563000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Common Stock: 7000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6623000000.00
AGNCO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1085000000.00
AGNCO cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
AGNCO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 362000000.00
AGNCO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 32000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Dividends Payable: 115000000.00
AGNCO cash_flow (annual, 2023-12-31) — End Cash Position: 1771000000.00
AGNCO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 14227000000.00
AGNCO cash_flow (annual, 2023-12-31) — Free Cash Flow: -118000000.00
AGNCO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 1567000000.00
AGNCO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 497000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -517000000.00
AGNCO income_statement (annual, 2023-12-31) — General And Administrative Expense: 62000000.00
AGNCO balance_sheet (annual, 2023-12-31) — Goodwill: 526000000.00